---
title: "Biohaven Pharmaceutical (BHVN.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/BHVN.US/norm.md"
symbol: "BHVN.US"
name: "Biohaven Pharmaceutical"
parent: "https://longbridge.com/zh-CN/quote/BHVN.US.md"
datetime: "2026-03-14T06:31:25.506Z"
locales:
  - [en](https://longbridge.com/en/quote/BHVN.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/BHVN.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/BHVN.US/norm.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/BHVN.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/BHVN.US/norm.md)


# Biohaven Pharmaceutical (BHVN.US) — 财务报表

## 利润表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -1.21 | -1.64 | -1.94 | -2.17 | -1.85 |
| ROE | -3335.36% | -1181.62% | -402.25% | -259.68% | -202.14% |
| Revenue | - | - | - | - | - |
| Net income | -145.56M | -173.44M | -198.15M | -221.68M | -186.84M |
| Operating income | -105.72M | -169.38M | -211.70M | -221.56M | -189.93M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 451.45M | 409.12M | 550.41M | 458.95M | 615.11M |
| Leverage | 8.67 | -23.84 | 4.09 | 1.77 | 1.45 |
| BVPS | 0.3922 | -0.1622 | 1.27 | 2.54 | 4.18 |
| Turnover | - | - | - | - | - |
| Cash & STI | 319.14M | 260.22M | 404.98M | 322.75M | 485.99M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 61.02M | 62.72M | 52.84M | 53.22M | 53.71M |
| Net debt | -34.52M | 53.96M | -113.42M | -287.24M | -449.41M |

## 现金流量表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -130.66M | -145.72M | -167.94M | -165.12M | -170.74M |
| Investing CF | -13.74M | 164.97M | -15.55M | 164.88M | -87.68M |
| Financing CF | 188.80M | 122000.00 | 249.83M | 369000.00 | 272.85M |
| Free CF | -29.69M | -86.88M | -159.29M | -82.25M | -92.59M |
| OCF coverage | -1633275.00% | -1120892.31% | -72075.54% | -35818.66% | -348453.06% |
| Repaid & issued | 0.0000 | 0.0000 | 250.00M | - | - |
| CapEx | -8000.00 | -13000.00 | -233000.00 | -461000.00 | -49000.00 |